Osteoarthritis Treatment
Start every patient with the core triad of exercise, weight loss (if overweight/obese), and patient education—these are non-negotiable first-line interventions that must be implemented before or alongside any pharmacological therapy. 1, 2, 3
Core Treatments (Mandatory for All Patients)
Non-Pharmacological Foundation
- Exercise programs including strengthening exercises (targeting local muscle groups around affected joints), aerobic fitness training (at least 30 minutes most days), and aquatic exercise for those unable to tolerate land-based activities 1, 2, 3
- Weight loss is mandatory for overweight or obese patients—even 5-10% body weight reduction significantly reduces joint pain and mechanical stress on weight-bearing joints 2, 3, 4
- Patient education to counter the misconception that osteoarthritis is inevitably progressive and untreatable, emphasizing self-management strategies and behavioral modifications 1, 2
Pharmacological Treatment Algorithm
Step 1: First-Line Analgesics
- Paracetamol (acetaminophen) up to 4,000 mg/day in divided doses for mild to moderate pain, though recent evidence shows limited efficacy 1, 2, 3
- Topical NSAIDs are strongly preferred for knee and hand osteoarthritis before oral NSAIDs due to effective pain relief with minimal systemic exposure 1, 2, 3
- Topical capsaicin can be considered as an adjunct for localized pain 1
Step 2: Oral NSAIDs (When Topical Therapy Insufficient)
- Use oral NSAIDs or COX-2 inhibitors at the lowest effective dose for the shortest duration 1, 2
- Always prescribe with a proton pump inhibitor (choose the lowest acquisition cost option) for gastroprotection 1
- Mandatory risk assessment before initiating: evaluate cardiovascular risk, gastrointestinal history, renal function, age, and concomitant aspirin use 1, 2
- For patients on low-dose aspirin, exhaust other analgesic options before adding NSAIDs due to compounded gastrointestinal risk 1
- Naproxen has been shown to cause statistically significantly less gastric bleeding than aspirin in controlled studies 5
Step 3: Additional Pharmacological Options
- Opioid analgesics (such as tramadol) only when paracetamol and topical NSAIDs are insufficient—add to or substitute for first-line agents, but reserve for refractory cases due to dependence risk 1, 2, 3
- Duloxetine is conditionally recommended for patients with inadequate response to first-line treatments or comorbid depression 3
Step 4: Intra-Articular Injections
- Corticosteroid injections for moderate to severe pain, particularly effective during acute flares—provide short-term relief for knee, hip, and shoulder osteoarthritis 1, 2, 3, 4
- Consider for patients with persistent symptoms despite oral therapy 3, 4
Adjunctive Non-Pharmacological Treatments
Physical Modalities
- Local heat or cold applications for temporary symptomatic relief 1, 2, 3
- Manual therapy (manipulation and stretching), particularly beneficial for hip osteoarthritis 1, 3
- Transcutaneous electrical nerve stimulation (TENS) for pain management 1, 2, 3
Biomechanical Interventions
- Shock-absorbing shoes or insoles to reduce joint impact 1
- Bracing and supports: tibiofemoral bracing for tibiofemoral OA (strongly recommended), patellofemoral bracing for patellofemoral OA, and first carpometacarpal joint orthoses for hand OA 3
- Assistive devices (walking sticks, canes, tap turners) for patients with functional limitations—canes are strongly recommended for hip OA 1, 3
Behavioral Modifications
- Pacing activities to avoid peaks and troughs of joint stress 1, 2
- Appropriate footwear with shock-absorbing properties 1, 4
Treatments NOT Recommended
- Glucosamine and chondroitin products are not recommended—insufficient evidence of benefit over placebo 1, 2, 3
- Intra-articular hyaluronan injections are not recommended for routine use 1
- Electroacupuncture should not be used 1, 3
- Rubefacients are not recommended 1
Surgical Referral Criteria
When to Refer for Joint Replacement
- Refer when joint symptoms (pain, stiffness, reduced function) substantially affect quality of life and are refractory to comprehensive non-surgical treatment 1
- Refer before prolonged and established functional limitation develops—do not wait until severe disability occurs 1
- Patient-specific factors (age, sex, smoking, obesity, comorbidities) should NOT be barriers to referral 1
- Ensure the patient has been offered at least the core treatment options (exercise, weight loss, education) plus appropriate pharmacological trials before surgical consideration 1
Arthroscopic Procedures
- Do NOT routinely refer for arthroscopic lavage and debridement unless the patient has knee osteoarthritis with a clear history of mechanical locking 1
- Common inappropriate reasons for arthroscopic referral include gelling, "giving way," or x-ray evidence of loose bodies without mechanical symptoms 1
Monitoring and Follow-Up
- Periodic review tailored to individual needs as disease course and requirements change over time 1, 2
- Monitor renal and hepatic function when using NSAIDs, particularly in elderly patients and those with comorbidities 1, 2, 4
- Reassess at 6-12 weeks to determine if escalation of therapy is needed 4
- Regular assessment of treatment effectiveness and adjustment of the management plan in partnership with the patient 1, 2
Critical Pitfalls to Avoid
- Do not combine NSAIDs with aspirin without gastroprotection—this significantly increases gastrointestinal bleeding risk 1
- Do not use NSAIDs and aspirin together routinely—the combination may result in higher frequency of adverse events than either alone 5
- Do not delay surgical referral until severe disability is established—refer when quality of life is substantially affected despite conservative treatment 1
- Do not underutilize core non-pharmacological treatments—exercise and weight management are frequently neglected but are essential components of effective OA management 6
- Avoid overreliance on opioid analgesics—these should be reserved for refractory cases after exhausting safer alternatives 2, 3, 6